thalidomide has been researched along with Hemangiosarcoma in 5 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Hemangiosarcoma: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
Excerpt | Relevance | Reference |
---|---|---|
"To investigate thalidomide as an adjuvant treatment for canine haemangiosarcoma." | 7.88 | Does thalidomide prolong survival in dogs with splenic haemangiosarcoma? ( Bray, JP; Cave, N; Munday, JS; Orbell, G, 2018) |
"To investigate thalidomide as an adjuvant treatment for canine haemangiosarcoma." | 3.88 | Does thalidomide prolong survival in dogs with splenic haemangiosarcoma? ( Bray, JP; Cave, N; Munday, JS; Orbell, G, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bray, JP | 1 |
Orbell, G | 1 |
Cave, N | 1 |
Munday, JS | 1 |
Kayaci, S | 1 |
Yildiz, O | 1 |
Gucer, H | 1 |
Mandel, NM | 1 |
Fraiman, G | 1 |
Ganti, AK | 1 |
Potti, A | 1 |
Mehdi, S | 1 |
Raina, V | 1 |
Sengar, M | 1 |
Shukla, NK | 1 |
Deo, SS | 1 |
Mohanty, BK | 1 |
Sharma, D | 1 |
Ray, R | 1 |
Das, P | 1 |
Rath, GK | 1 |
Roe, FJ | 1 |
Walters, MA | 1 |
5 other studies available for thalidomide and Hemangiosarcoma
Article | Year |
---|---|
Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
Topics: Angiogenesis Inhibitors; Animals; Chemotherapy, Adjuvant; Dog Diseases; Dogs; Female; Hemangiosarcom | 2018 |
Angiosarcoma of the liver with metastasis to the cervical spine cured with the treatment of thalidomide and radiotherapy.
Topics: Angiogenesis Inhibitors; Biopsy; Cervical Vertebrae; Chemoradiotherapy; Hemangiosarcoma; Humans; Liv | 2012 |
Angiosarcoma of the small intestine: a possible role for thalidomide?
Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Angiogenesis Inhibitors; Hemangiosarcoma; Humans; | 2003 |
Complete response from thalidomide in angiosarcoma after treatment of breast cancer.
Topics: Aged; Breast Neoplasms; Female; Hemangiosarcoma; Humans; Thalidomide | 2007 |
Sensitivity of newborn mice to carcinogenic agents.
Topics: Adenocarcinoma; Adenoma; Animals; Animals, Newborn; Benz(a)Anthracenes; Carcinogens; Carcinoma, Hepa | 1968 |